11 completed. 5 Phase 1, 5 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow PLx Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacodynamic and Pharmacokinetic Study of PL-ASA PL-ASA - Healthy Volunteers | Phase 4 | Completed | PLx Pharma | 36 | 2021-04-28 | 2022-04-25 |
| Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers. Pharmaceutical-lipid aspirin (PL-ASA) - Bioequivalence | Phase 1 | Completed | PLx Pharma | 24 | 2020-05-07 | 2022-04-27 |
| Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients PL2200 Aspirin Capsules, Enteric-coated aspirin caplets - Diabetes Mellitus, Type 2 | Phase 3 | Completed | PLx Pharma | 57 | 2014-01-01 | 2016-03-10 |
| Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects PL2200, Aspirin tablets - Gastroduodenal Ulceration | Phase 2 | Completed | PLx Pharma | 247 | 2012-09-01 | 2022-06-07 |
| Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients PL2200 Aspirin Capsules, Immediate-Release Aspirin Tablets, Enteric-coated aspirin caplets - Diabetes Mellitus, Type 2 | Phase 3 | Completed | PLx Pharma | 40 | 2012-01-01 | 2016-03-14 |
| Food-Effect Pharmacokinetic Study of PL2200 PL2200 fasted, PL2200 fed - Healthy | Phase 1 | Completed | PLx Pharma | 20 | 2010-10-01 | 2010-12-13 |
| Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults PL3100, Naproxen - Gastroduodenal Ulcerations, Erosion | Phase 2 | Completed | PLx Pharma | 77 | 2010-07-01 | 2016-04-11 |
| Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adults Naproxen, PL 3100 - Healthy Volunteers | Phase 1 / Phase 2 | Completed | PLx Pharma | 34 | 2009-08-01 | 2015-09-07 |
| Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers acetylsalicylic acid - Upper Gastrointestinal Mucosal Damage | Phase 1 / Phase 2 | Completed | PLx Pharma | 204 | 2009-01-01 | 2015-08-11 |
| Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex Aspirin - Bioequivalence | Phase 1 | Completed | PLx Pharma | 32 | 2008-02-11 | 2019-07-05 |
| Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial Ibuprofen-PC - Osteoarthritis | Phase 2 | Completed | PLx Pharma | 125 | 2005-01-01 | 2008-11-26 |
Diabetes Mellitus, Type 2 (2) · Osteoarthritis (1)
Aspirin (3) · Naproxen (2) · aspirin-phosphatidylcholine (1)
United States (9)
Alan J Kivitz, MD (1) · Byron L Cryer, MD (1) · Francesco Franchi, MD (1) · Frank L Lanza, MD (1) · Howard Schwartz, MD (1) · Michael E Schwartz, DO (1) · Phillip B Miner, MD (1) · Upendra K Marathi, PhD (1) · Upendra K. Marathi, PhD (1) · Upendra Marathi, PhD (1)
PMID 28089180, PMID 31420787, PMID 32080811, PMID 36036856
1RC3AR059535-01 (1)